AMED - Amedisys, Inc.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Baton Rouge,
United States
Type: Equity
AMED price evolution
AMED
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $157.36 | $120.7 | $138.86 | $94.02 |
| Short term investments | ||||
| Net receivables | $356.91 | $359.36 | $313.37 | $319.58 |
| Inventory | ||||
| Total current assets | $555.9 | $526.45 | $496.94 | $467.23 |
| Long term investments | ||||
| Property, plant & equipment | $129.35 | $131.11 | $130.78 | $127.47 |
| Goodwill & intangible assets | $1345.51 | $1346.46 | $1347.35 | $1348.31 |
| Total noncurrent assets | $1561.47 | $1563.42 | $1563.23 | $1560.19 |
| Total investments | ||||
| Total assets | $2117.37 | $2089.87 | $2060.17 | $2027.42 |
| Current liabilities | ||||
| Accounts payable | $26.63 | $36.25 | $28.24 | $34.55 |
| Deferred revenue | ||||
| Short long term debt | $64.19 | $63.52 | $62.6 | $61.48 |
| Total current liabilities | $479.98 | $484.86 | $473.72 | $468.12 |
| Long term debt | $410.45 | $418.3 | $424.61 | $428.73 |
| Total noncurrent liabilities | $458.51 | $462.36 | $466.67 | $465.78 |
| Total debt | $474.64 | $481.82 | $487.21 | $490.21 |
| Total liabilities | $938.48 | $947.22 | $940.39 | $933.9 |
| Shareholders' equity | ||||
| Retained earnings | $794.63 | $762.33 | $747.92 | $728.6 |
| Other shareholder equity | ||||
| Total shareholder equity | $1125.2 | $1088.18 | $1066.51 | $1039.91 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $138.86 | $54.13 | $45.77 | $83.36 |
| Short term investments | ||||
| Net receivables | $313.37 | $309.19 | $274.96 | $255.15 |
| Inventory | ||||
| Total current assets | $496.94 | $388.96 | $356.68 | $361.98 |
| Long term investments | ||||
| Property, plant & equipment | $130.78 | $118.88 | $119.69 | $117.16 |
| Goodwill & intangible assets | $1347.35 | $1388.57 | $1307.28 | $1006.87 |
| Total noncurrent assets | $1563.23 | $1587.28 | $1500.28 | $1205.21 |
| Total investments | ||||
| Total assets | $2060.17 | $1976.24 | $1856.97 | $1567.2 |
| Current liabilities | ||||
| Accounts payable | $28.24 | $43.73 | $38.22 | $42.67 |
| Deferred revenue | ||||
| Short long term debt | $62.6 | $49.02 | $44.23 | $40.54 |
| Total current liabilities | $473.72 | $355.53 | $374.28 | $456.34 |
| Long term debt | $424.61 | $419.42 | $501.38 | $266.5 |
| Total noncurrent liabilities | $466.67 | $514.14 | $506.36 | $300.12 |
| Total debt | $487.21 | $537.94 | $545.61 | $307.04 |
| Total liabilities | $940.39 | $924.67 | $880.64 | $756.46 |
| Shareholders' equity | ||||
| Retained earnings | $747.92 | $757.67 | $639.06 | $429.99 |
| Other shareholder equity | $1.43 | |||
| Total shareholder equity | $1066.51 | $1051.57 | $931.35 | $809.22 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $591.19 | $571.41 | $570.79 | $556.24 |
| Cost of revenue | $326.93 | $321.54 | $321.42 | $311.63 |
| Gross Profit | $264.25 | $249.88 | $249.37 | $244.61 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $129.32 | $127.95 | $135.12 | $129.08 |
| Total operating expenses | $212.04 | $218.26 | $215.36 | $202.4 |
| Operating income | $52.21 | $31.62 | $34.01 | $42.21 |
| Income from continuing operations | ||||
| EBIT | $56.85 | $35.15 | $37.73 | $46.31 |
| Income tax expense | $16.66 | $12.63 | $10.18 | $12.33 |
| Interest expense | $7.89 | $8.12 | $8.23 | $8.02 |
| Net income | ||||
| Net income | $32.3 | $14.4 | $19.32 | $25.96 |
| Income (for common shares) | $32.3 | $14.4 | $19.32 | $25.96 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2236.38 | $2223.2 | $2214.11 | $2071.52 |
| Cost of revenue | $1245.51 | $1260.42 | $1233.36 | $1185.37 |
| Gross Profit | $990.87 | $962.77 | $980.76 | $886.15 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $516.05 | $508.79 | $474.72 | $449.45 |
| Total operating expenses | $834.48 | $782 | $728.84 | $666.88 |
| Operating income | $156.39 | $180.77 | $251.91 | $219.27 |
| Income from continuing operations | ||||
| EBIT | $72.09 | $183.38 | $288.66 | $220.28 |
| Income tax expense | $50.56 | $42.55 | $70.06 | $25.64 |
| Interest expense | $31.27 | $22.23 | $9.53 | $11.04 |
| Net income | ||||
| Net income | -$9.75 | $118.61 | $209.07 | $183.61 |
| Income (for common shares) | -$9.75 | $118.61 | $209.07 | $183.61 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $32.3 | $14.4 | $19.32 | $25.96 |
| Operating activities | ||||
| Depreciation | $14.89 | $14.7 | $14.46 | $14.52 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $8.3 | $7.89 | $9.4 | $7.24 |
| Total cash flows from operations | $52.3 | -$6.54 | $60.31 | -$9.84 |
| Investing activities | ||||
| Capital expenditures | -$1.39 | -$2.67 | -$1.86 | -$0.98 |
| Investments | -$0.2 | $0.15 | ||
| Total cash flows from investing | -$1.57 | -$3.07 | -$2.04 | -$1.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.87 | |||
| Net borrowings | -$9.44 | -$8.94 | -$8.9 | -$6.12 |
| Total cash flows from financing | -$14.08 | -$8.55 | -$13.43 | -$6.25 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $36.65 | -$18.16 | $44.85 | -$17.14 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$9.75 | $118.61 | $209.07 | $183.61 |
| Operating activities | ||||
| Depreciation | $57.84 | $70.96 | $71.27 | $67.94 |
| Business acquisitions & disposals | $47.44 | -$71.95 | -$269.96 | -$298.96 |
| Stock-based compensation | $29.02 | $16.56 | $23.81 | $26.73 |
| Total cash flows from operations | $137.19 | $133.28 | $188.89 | $288.95 |
| Investing activities | ||||
| Capital expenditures | -$5.48 | -$6.1 | -$6.16 | -$5.25 |
| Investments | $0.15 | -$15.64 | -$5.2 | $17 |
| Total cash flows from investing | $35.06 | -$94.49 | -$281.61 | -$287.11 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.7 | -$11.2 | -$93.86 | $9.89 |
| Net borrowings | -$76.01 | -$13.3 | $227.38 | -$29.25 |
| Total cash flows from financing | -$87.52 | -$30.43 | $55.13 | -$14.98 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $84.73 | $8.36 | -$37.59 | -$13.13 |
News
Fundamentals
| Market cap | $3.18B |
|---|---|
| Enterprise value | $3.50B |
| Shares outstanding | 32.74M |
| Revenue | $2.29B |
|---|---|
| EBITDA | $234.63M |
| EBIT | $176.05M |
| Net Income | $91.98M |
| Revenue Q/Q | 6.91% |
| Revenue Y/Y | 2.70% |
| P/E ratio | 34.59 |
|---|---|
| EV/Sales | 1.53 |
| EV/EBITDA | 14.91 |
| EV/EBIT | 19.87 |
| P/S ratio | 1.39 |
| P/B ratio | 2.83 |
| Book/Share | 34.37 |
| Cash/Share | 4.81 |
| EPS | $2.81 |
|---|---|
| ROA | 4.44% |
| ROE | 8.52% |
| Debt/Equity | 0.88 |
|---|---|
| Net debt/EBITDA | 3.33 |
| Current ratio | 1.16 |
| Quick ratio | 1.16 |